Promius Pharma, LLC Launches Promiseb(TM) Cream 7/28/2009
More...
|
Onset Therapeutics Launches HYLATOPIC(TM) Emollient Foam for Atopic Dermatitis 7/14/2009
More...
|
Basilea Pharmaceutica's Toctino(R) (Alitretinoin) Included In New Dermatology Treatment Guidelines In Germany 3/26/2009
More...
|
Drug Used To Treat Skin Conditions Is A Marine Pollutant, University of Gothenburg Study 3/24/2009
More...
|
Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option For Skin Disorder, University of Minnesota Study 12/5/2008
More...
|
Revotar Biopharmaceuticals Reports Positive Preclinical Data From A 4-Month Dermal Toxicity Study 10/29/2008
More...
|
Targanta Therapeutics Presents Efficacy and Safety Data for Oritavancin for the Treatment of Gram-Positive Complicated Skin and Skin Structure Infections (cSSSI) 10/27/2008
More...
|
DermTech International And Rady Children’s Hospital-San Diego, Initiate Study To Understand Effects Of Vitamin D As A Treatment For Atopic Dermatitis In Children And Young Adults 10/27/2008
More...
|
Dr. Reddy's Laboratories Ltd. (RDY) Wholly-Owned Subsidiary Promius Pharma, LLC Launches EPICERAM(R) Skin Barrier Emulsion 10/14/2008
More...
|
Barrier Therapeutics, Inc. (BTRX) Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis 7/28/2008
More...
|
ALIGN Pharmaceuticals, Inc. Release: Xclair® Reported to Be Safe and Effective in Study Published in European Journal of Dermatology 7/7/2008
More...
|
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Submits 510(k) Application to FDA for Xyfid(TM), a Novel Topical Agent for the Treatment of Various Skin Disorders 7/1/2008
More...
|
Oculus Innovative Sciences, Inc. (OCLS) Announces Positive Results from Abstract Evaluating the Use of Microcyn® Technology in Treatment of Atopic Dermatitis 7/1/2008
More...
|
Oculus Innovative Sciences, Inc. (OCLS) Announces Development of Microcyn®-Based Hydrogel Formulation 6/17/2008
More...
|
Ferndale Laboratories, Inc. and Foamix Execute License Agreement for Development of Non-Steroidal Foam for Atopic Dermatitis 6/3/2008
More...
|
Graceway Pharmaceuticals, LLC Reports Study in Journal of Pediatrics: ATOPICLAIR(R) is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children 5/29/2008
More...
|
Provectus Pharmaceuticals Inc. Begins Phase 2 Clinical Trial for Atopic Dermatitis 5/28/2008
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Announces Results of a Comparison Study of the Safety and Efficacy of EpiCeram(R) Cream for the Treatment of Mild to Moderate Pediatric Atopic Dermatitis 5/20/2008
More...
|
Moberg Derma Starts Recruiting Patients for Clinical Phase III Trial for its K301 Product Candidate to Treat Seborrheic Dermatitis 2/22/2008
More...
|
JADO Technologies Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis 2/18/2008
More...
|
Pfizer Inc. (PFE) Receives Approvable Letter from FDA for Dalbavancin 12/26/2007
More...
|
Astion Pharma to Commence International Phase III Clinical Studies With ASF-1057 in Seborrheic Dermatitis 12/10/2007
More...
|
Ferndale Laboratories, Inc. and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis 11/5/2007
More...
|
A.T.S. Pharmaceuticals Launches Zytopic(TM) Cream for the Treatment of Atopic Dermatitis 10/31/2007
More...
|
Moberg Derma Reports Positive Phase II Results for Its K301 Product Candidate for the Treatment of Seborrheic Dermatitis 9/10/2007
More...
|
AGI Dermatics Release: Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients 9/5/2007
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Provides Update on EpiCeram(R); Licensing Deal Delayed 8/22/2007
More...
|
Combination of Limes, Sun Can Result in 'Margarita Dermatitis' 8/16/2007
More...
|
Barrier Therapeutics, Inc. (BTRX) Introduces New Xolegel Duo(TM) Offering at the American Academy of Dermatology Summer Academy Meeting 2007 8/2/2007
More...
|
FDA Approves Stiefel Laboratories' Extina(R) for the Treatment of Seborrheic Dermatitis 7/17/2007
More...
|
DermTech International and University of California, San Francisco (UCSF) Collaborate to Explore Potential of Company's EGIR Technology to Develop Novel Compounds for Anti-Aging and Atopic Dermatitis 5/11/2007
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints 4/24/2007
More...
|
Futura Medical Launches DermaSys As Brand Name for Proprietary Drug Delivery Technology 2/28/2007
More...
|
Ipsen Grants Anti-Wrinkle Drug Rights To Galderma 2/26/2007
More...
|
Prime Pharmaceutical Corporation Announces Positive Results Of In Vitro Studies And An Open Label Trial For Relieva(R) In Treating Atopic Dermatitis 2/22/2007
More...
|
Basilea Pharmaceutica Reports Positive Phase III Results For Alitretinoin 2/19/2007
More...
|
Morria Biopharmaceuticals Inc. Announces Publication Of The Results Of Its Human Pilot Study In Contact Dermatitis Patients Of MRX1, A Novel First-in-Class MFAID 2/14/2007
More...
|
Anacor Pharmaceuticals, Inc. Presents Research And Clinical Findings From Three Programs At AAD Meeting 2/5/2007
More...
|
AGI Dermatics Presents Comparative Data That Indicates L-ergothioneine (EGT) Reduces UVA340-Induced Hydrogen Peroxide More Efficiently Than Idebenone 2/5/2007
More...
|
AGI Dermatics Presents Comparative Data Of 4% Hydroquinone Products On Melanocyte Morphology 2/5/2007
More...
|
Barrier Therapeutics, Inc. (BTRX) Announces Positive Phase 2a Data For Oral Hivenyl(TM) In The Treatment Of Itch In Atopic Dermatitis 1/18/2007
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Provides Update On Clinical Study 1/17/2007
More...
|
Perrigo Company (PRGO) Announces FDA Approval For Ciclopirox Topical Suspension 12/19/2006
More...
|
Glucocorticoid Plays Key Role In Skin Abnormalities Induced By Psychological Stress 12/1/2006
More...
|
Warner Chilcott Licenses Worldwide Rights To Schering AG (SHR)'s SEGRA Compound For Dermatologic Indications And Announces Settlement Of Yaz(R) Patent Litigation 11/14/2006
More...
|
Connetics Corporation (CNCT) Launches Verdeso Foam For The Treatment Of Mild-to-Moderate Atopic Dermatitis In Children And Adults 11/9/2006
More...
|
CuraGen Corporation (CRGN) And TopoTarget A/S Out-License Worldwide Rights For Preclinical HDAC Inhibitor 11/2/2006
More...
|
Astion Pharma Initiates Phase 2B Program With ASF-1057 In Seborrheic Dermatitis 10/24/2006
More...
|
SkinMedica Announces FDA Approval Of Desonate(TM) (Desonide) Gel 0.05% With Patented Hydrogel Technology For Treatment Of Atopic Dermatitis 10/23/2006
More...
|
Calgenex Corporation Introduces New Topical Psoriasis Treatment 9/27/2006
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Says Dermatitis Cream Fails Goal In Mid-Stage Trial 9/21/2006
More...
|
Stiefel Laboratories Endows Chair In Medical Dermatology 9/21/2006
More...
|
FDA Approves Connetics Corporation (CNCT)'s Verdeso Foam For The Treatment Of Mild-To-Moderate Atopic Dermatitis 9/20/2006
More...
|
Positive Results For Sinclair Pharmaceuticals's Eczema Drug 9/20/2006
More...
|
Barrier Therapeutics, Inc. (BTRX) Receives FDA Approval Of Xolegel(TM) Gel For The Treatment Of Seborrheic Dermatitis 7/31/2006
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Obtains IRB Approval For Eczema Clinical Study 6/27/2006
More...
|
Anacor Pharmaceuticals, Inc. Announces Positive Results From Phase 2 Trial Of Novel Anti-Inflammatory Agent For The Treatment Of Atopic Dermatitis 6/15/2006
More...
|
Steroid Lotion Effective For Eczema In Young Kids 5/1/2006
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Completion Of Patient Enrollment In Second Phase 2 Clinical Trial Of Topical Cream For The Treatment Of Atopic Dermatitis 4/28/2006
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Receives 510k Clearance Of EpiCeram(R) For The Treatment Of Atopic Dermatitis And Other Skin Disorders 4/12/2006
More...
|
Cephalon, Inc. (CEPH) Drug A Victim Of ADHD Debate: Experts 3/30/2006
More...
|
Kikkoman, Tohoku University Confirm That Tomato Extract Helps Heal Atopic Dermatitis 3/10/2006
More...
|
Top 10 Causes Of Skin Allergy 3/9/2006
More...
|
Stiefel Laboratories Release: Study Shows New Atopic Dermatitis Therapy Significantly Delays Onset Of Flares 3/3/2006
More...
|
SkinMedica Reports Positive Results From Desonate(TM) Phase III Trials 2/22/2006
More...
|
Delaying Solid Food By 6m Doesn't Prevent Allergy 2/21/2006
More...
|
FDA Approves Barrier Therapeutics, Inc. (BTRX)'s Vusion(TM) Ointment For The Treatment Of Diaper Dermatitis Complicated By Candidiasis 2/17/2006
More...
|
Corticosteroids Can Contribute To Osteoporosis 1/19/2006
More...
|
Xolair "Add-On" Helpful In Uncontrolled Dermatitis 1/13/2006
More...
|
Stiefel Laboratories Release: New Product Approved By FDA Takes Novel Approach To Atopic Dermatitis 10/20/2005
More...
|
Probiotics Help Dermatitis In Children, New Evidence 10/11/2005
More...
|
AnGes MG Inc. Finally Starts Phase I Clinical Trial Of NF-kappa B Decoy Oligodeoxynucleotide For Atopic Dermatitis 10/4/2005
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Signs License Option Agreement With European Pharmaceutical Company; Deal Potentially Worth More Than $10 Million 9/14/2005
More...
|
Connetics Corporation (CNCT) Reports Positive Results From Desilux Phase III Trial; NDA Submission Anticipated By Year End For First Drug Using Patented Emollient Foam Technology 8/15/2005
More...
|
AnGes MG Inc. To Start Phase I Clinical Trial Of NF-kappa B Decoy Oligodeoxynucleotide For Atopic Dermatitis 7/26/2005
More...
|
Positive Results Of CollaGenex Pharmaceuticals, Inc.'s (CGPI) Phase 3 Clinical Studies Evaluating Effects Of Oracea (Doxycycline Controlled Release Capsules) As Treatment For Rosacea Presented At Summer Meeting Of The American Academy of Dermatology 7/25/2005
More...
|
Alfresa Pharma, AnGes MG Inc. Sign Joint Development Contract For Atopic Dermatitis Drug 7/11/2005
More...
|
AVANIR Pharmaceuticals (AVN) Submits NDA For Neurodex(TM) 6/30/2005
More...
|
Sinclair Pharmaceuticals Announces Positive Trial Results: US Multicentre Trial Confirms Efficacy Of AtopiclairTM In Atopic Dermatitis AtopiclairTM launched In The US 6/21/2005
More...
|
Connetics Corporation (CNCT) To Resume Extina Development With New Phase III Trial 6/8/2005
More...
|
Bayer HealthCare AG (BAY) Spin-Out, Actimis Pharmaceuticals, Inc., Completes $6 Million Series A Financing 4/28/2005
More...
|
OnSource Corporation (OSCE.OB) Executes Definitive Merger Agreement With Osmotics Pharma, Inc. (OPI); Provides For Entry Into Specialty Pharmaceuticals 4/12/2005
More...
|
Maruho, Toray Industries, Inc. To Collaborate In Developing And Marketing Candidate Compound For Atopic Dermatitis Drug 4/1/2005
More...
|
Kirin Bacteria May Prevent Dermatitis 3/29/2005
More...
|
Connetics Corporation (CNCT) Commences Phase III Clinical Trial With Primolux For Atopic Dermatitis And Psoriasis; Second Drug Program To Include Connetics' Patented Emollient Foam Technology 3/24/2005
More...
|
Corgentech, Inc. (CGTK) Files Investigational New Drug Application To Begin Phase 1/2 Trial Of New Drug Candidate For Eczema 1/12/2005
More...
|
Barrier Therapeutics, Inc. (BTRX) Announces Positive Phase 3 Results For Pivotal Study With Sebazole(TM) 12/16/2004
More...
|
Pharmaceuticals And Medical Devices Agency To Support AnGes MG Inc.'s Research On NFkB Decoy Oligodeoxynucleotide 12/13/2004
More...
|
Connetics Corporation (CNCT) Receives FDA Non-Approvable Letter For Extina 11/24/2004
More...
|
Young Volunteers Needed For Stanford/Packard Study 11/24/2004
More...
|
Stanford University Medical Center Release: Young Volunteers Needed For Stanford/Packard Study To Test Whether Infant Rash Cream Prevents Asthma 11/19/2004
More...
|
Axm Pharma, Inc. (AXJ) Awarded 42 Drug Licenses By Chinese Government 11/15/2004
More...
|
Company Profile For Medicis 10/29/2004
More...
|
Connetics Corporation (CNCT) Commences Phase III Clinical Trial For Desilux 9/27/2004
More...
|
Westaim's NUCRYST Pharmaceuticals (WEDX) Reports Phase 2a Clinical Trial Results Of Investigational Drug In Atopic Dermatitis 9/8/2004
More...
|
Webcast Of Conference Call To Discuss NUCRYST Pharmaceuticals' (WEDX) Results Of Phase 2a Trials 9/8/2004
More...
|
Barrier Therapeutics, Inc. (BTRX) Announces Positive Phase III Data On Zimycan(TM) 8/11/2004
More...
|
The Quigley Corporation (QGLY) Receives U.S. Patent For Its Topical Treatment For Radiation Dermatitis 7/12/2004
More...
|
SkinMedica To Acquire VANIQA To Expand Prescription Dermatology Product Line; $36.6 Million 6/28/2004
More...
|
Barrier Therapeutics, Inc. (BTRX) Initiates Phase III Clinical Trial With Sebazole(TM) 5/26/2004
More...
|
Barrier Therapeutics, Inc. (BTRX) Receives Marketing Authorization For Zimycan(TM) From Belgian Health Authority 5/19/2004
More...
|
FDA Grants IND To Bavarian Nordic (DK:BAVA); Trial With IMVAMUNE Smallpox Vaccine In Atopic Dermatitis To Begin 5/5/2004
More...
|
Kirin Brewery Co., Ltd.'s (KNBWY) Lactobacillus KW Found Effective Against Atopic Dermatits 4/1/2004
More...
|
AEterna Laboratories Inc. (AELA) Reports 2003 Fourth Quarter And Full Year Financial Results 2/27/2004
More...
|
Lerner Medical Devices, Inc. Announces 510(k) Clearance And Market Availability Of The Levia(TM) Phototherapy System 2/26/2004
More...
|
Encysive Pharmaceuticals (ENCY) To Present At Biotechnology Industry Organization (BIO) CEO And Investor Conference 2004 2/19/2004
More...
|
Connetics Corporation (CNCT) Presents 11 Scientific Posters At American Academy of Dermatology's 62nd Annual Meeting 2/6/2004
More...
|
Quigley Corporation (QGLY) Provides Updates On Quigley Pharma's Business And Research Activities 1/20/2004
More...
|
Bradley Pharmaceuticals (BDY) Launches 3 New Dermatology Product Line Extensions 1/20/2004
More...
|
LAM Pharmaceutical Corporation (LAMP) Expands Product Line By Introducing Veterinary Offering 1/15/2004
More...
|
CureLight Ltd. Release: New Phototherapy Technology Developed In Israel To Treat Psoriasis, Vitiligo, Atopic Dermatitis And Leukoderma Gets FDA Clearance 1/13/2004
More...
|
Barrier Therapeutics, Inc. Reports Results From Phase III Seborrheic Dermatitis Studies 1/12/2004
More...
|
Kids' Acting Out May Signal Asthma Onset 12/30/2003
More...
|
Cardinal Health (CAH) Introduces Medical Gloves That Help Improve Skin, Relieve Dermatitis 12/9/2003
More...
|
NUCRYST Pharmaceuticals (WEDX) Begins First Phase 2 Clinical Trial Of Novel Dermatology Drug 12/4/2003
More...
|
Nickel Causing Workplace Skin Disease 11/25/2003
More...
|
3M Pharmaceuticals (MMM) And Novartis Pharma AG (NVS) Agree To Co-Market Skin Medication In Germany 11/13/2003
More...
|